Heron Therapeutics is a commercial-stage biotechnology company focused on acute care and oncology. Its portfolio includes ZYNRELEF (dual-acting local anesthetic for postoperative pain), APONVIE (IV aprepitant for postoperative nausea and vomiting), CINVANTI (IV aprepitant for chemotherapy-induced nausea and vomiting), and SUSTOL (extended-release injectable granisetron for chemotherapy-induced nausea and vomiting). The company uses its proprietary Biochronomer Technology for sustained drug delivery and commercializes products through a U.S.-based sales force of 78 employees.
expected 2026-11-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073515 | EDGAR | 69K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-028374 | EDGAR | 65K words |
| 2024-03-12 | 2023-12-31 | 0000950170-24-029951 | EDGAR | 62K words |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010603 | EDGAR | 63K words |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007618 | EDGAR | 62K words |
| 2021-02-24 | 2020-12-31 | 0001564590-21-007841 | EDGAR | 69K words |
| 2020-03-02 | 2019-12-31 | 0001564590-20-007973 | EDGAR | 66K words |
| 2019-02-22 | 2018-12-31 | 0001193125-19-047780 | EDGAR | 66K words |
| 2018-02-27 | 2017-12-31 | 0001193125-18-060951 | EDGAR | 56K words |
| 2017-02-23 | 2016-12-31 | 0001193125-17-054088 | EDGAR | 57K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001193125-26-341301 | EDGAR | 30K words |
| 2025-11-04 | 2025-09-30 | 0001193125-25-263618 | EDGAR | 26K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105475 | EDGAR | 25K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-063971 | EDGAR | 20K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124698 | EDGAR | 20K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091764 | EDGAR | 19K words |
| 2024-05-07 | 2024-03-31 | 0000950170-24-053964 | EDGAR | 16K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063714 | EDGAR | 19K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042431 | EDGAR | 18K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021237 | EDGAR | 17K words |
| 2022-11-08 | 2022-09-30 | 0001564590-22-037047 | EDGAR | 42K words |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028599 | EDGAR | 42K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-29 | 0001193125-26-407728 | EDGAR | 1K words |
| 2026-08-14 | 0001193125-26-352403 | EDGAR | 1K words |
| 2026-08-10 | 0001193125-26-341300 | EDGAR | 4K words |
| 2026-04-06 | 0001193125-26-142947 | EDGAR | 9K words |
| 2026-02-26 | 0001193125-26-073502 | EDGAR | 4K words |
| 2026-01-09 | 0001193125-26-008631 | EDGAR | 2K words |
| 2025-11-04 | 0001193125-25-263617 | EDGAR | 4K words |
| 2025-10-29 | 0001193125-25-256300 | EDGAR | 1K words |
| 2025-10-15 | 0001193125-25-240253 | EDGAR | 1K words |
| 2025-08-28 | 0000950170-25-112048 | EDGAR | 1K words |
364 total filings indexed. 332 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000818033 |
| Ticker | HRTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.herontx.com |
| Listed | 1987-08-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HRTX (~200 tokens, structured JSON with cryptographic provenance)